Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
3
×
boston
boston blog main
clinical trials
deals
fda
investing
480 biomedical
abide therapeutics
akouos
allergan
amylin pharmaceuticals
arsenal medical
astellas pharmaceuticals
ben cravatt
bob langer
boston top stories
botox
bristol-myers squibb
california institute for biomedical research
chronic rhinosinusitis
covid-19
decibel therapeutics
drug delivery
epilepsy
executives
frequency therapeutics
gabapentin
genzyme
george whitesides
harvard university
hearing loss
hiring
inflammation
ipo
jeffrey karp
keros therapeutics
kevin finney
What
developing
3
×
therapeutics
treat
3
×
ipo
medicines
abide
affects
americans
appointed
approved
biotech
chief
company
date
debut
diseases
drug
executive
fda
finney
frequency
hearing
kevin
late
loss
lyra
markets
meds
million
millions
neurological
new
nose
noses
officer
operating
persistently
plans
president
public
Language
unset
Current search:
" national blog main "
×
developing
×
treat
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President